Bristol-Myers Squibb Co. (BMY)

53.65
NYSE : Health Technology
Prev Close 53.65
Day Low/High 0.00 / 0.00
52 Wk Low/High 49.96 / 70.05
Avg Volume 8.58M
Exchange NYSE
Shares Outstanding 1.63B
Market Cap 89.57B
EPS 0.60
P/E Ratio 94.48
Div & Yield 1.60 (2.95%)
Jim Cramer: Will the Techs Be Challenged, Too?

Jim Cramer: Will the Techs Be Challenged, Too?

The theft of intellectual property can be confronted by a Section 301 challenge directly from the trade representative.

BMY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Bristol-Myers Squibb Company And A Lead Plaintiff Deadline Of April 10, 2018

BMY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Bristol-Myers Squibb Company And A Lead Plaintiff Deadline Of April 10, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Bristol-Myers Squibb...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CZR, ERII, IGT Downgrades: AAME, ANW, AVDL, BMY, COO, EGOV, MEET, MRVL, PCMI, VTR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Bristol-Myers Squibb Company Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Bristol-Myers Squibb Company Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Bristol-Myers Squibb Company ("Bristol-Myers") (NYSE:BMY)...

Bristol-Myers Squibb To Take Part In Barclays Global Healthcare Conference

Bristol-Myers Squibb To Take Part In Barclays Global Healthcare Conference

Bristol-Myers Squibb Company (NYSE: BMY) will present at Barclays Global Healthcare Conference on Wednesday, March 14, 2018, in Miami.

The Klein Law Firm Announces Commencement Of A Class Action On Behalf Of Bristol-Myers Squibb Company Shareholders And A Lead Plaintiff Deadline Of April 10, 2018 (BMY)

The Klein Law Firm Announces Commencement Of A Class Action On Behalf Of Bristol-Myers Squibb Company Shareholders And A Lead Plaintiff Deadline Of April 10, 2018 (BMY)

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Bristol-Myers Squibb Company (NYSE:BMY) who purchased shares between January 27, 2015 and October 9, 2016.

Bristol-Myers Squibb's Opdivo® (nivolumab) Now The First And Only FDA-Approved PD-1 Inhibitor To Offer Every Four-Week Dosing

Bristol-Myers Squibb's Opdivo® (nivolumab) Now The First And Only FDA-Approved PD-1 Inhibitor To Offer Every Four-Week Dosing

Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.

10 Stocks Investors Raced to Buy During February's Brutal Market Correction

10 Stocks Investors Raced to Buy During February's Brutal Market Correction

Sensing an opportunity, investors raced to eat up several big-cap stocks in February. Here are the biggest buys.

Bristol-Myers Squibb To Take Part In Cowen And Company 38th Annual Global Health Care Conference

Bristol-Myers Squibb To Take Part In Cowen And Company 38th Annual Global Health Care Conference

Bristol-Myers Squibb Company (NYSE:BMY) will participate in the Cowen and Company 38 th Annual Global Health Care Conference on Monday, March 12, 2018, in Boston.

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

Jim Cramer takes a look at Square, Manitowoc, Valley National Bancorp, FMC Corp., Universal Display, CIT Group, Oneok, and Albemarle.

Jim Cramer: Here's 10 Things to Watch For

Jim Cramer: Here's 10 Things to Watch For

You just have to look at it like a drill.

Jim Cramer: Here's 10 Things to Watch For

Jim Cramer: Here's 10 Things to Watch For

You just have to look at it like a drill.

CORRECTING and REPLACING Bristol-Myers Squibb Announces Dividend

CORRECTING and REPLACING Bristol-Myers Squibb Announces Dividend

Headline of release should read: Bristol-Myers Squibb Announces Dividend The corrected release reads: BRISTOL-MYERS SQUIBB ANNOUNCES DIVIDEND The Board of Directors of Bristol-Myers Squibb...

Bristol-Myers Squibb Names José Baselga, M.D., Ph.D. To Board Of Directors

Bristol-Myers Squibb Names José Baselga, M.D., Ph.D. To Board Of Directors

Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected José Baselga, M.

BMY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Bristol-Myers Squibb Company And A Lead Plaintiff Deadline Of April 10, 2018

BMY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Bristol-Myers Squibb Company And A Lead Plaintiff Deadline Of April 10, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Bristol-Myers Squibb...

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Bristol-Myers Squibb Company Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Bristol-Myers Squibb Company Of A Class Action And A Lead Plaintiff Deadline Of April 10, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Bristol-Myers Squibb Company ("Bristol-Myers") (NYSE:BMY)...

Bristol-Myers Squibb Announces Expansion Of The International Immuno-Oncology Network (II-ON) With Addition Of Yale Cancer Center

Bristol-Myers Squibb Announces Expansion Of The International Immuno-Oncology Network (II-ON) With Addition Of Yale Cancer Center

Bristol-Myers Squibb Company (NYSE:BMY) today announced that Yale Cancer Center has joined the International Immuno-Oncology Network (II-ON), a global peer-to-peer collaboration between Bristol-Myers Squibb and academia...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Bristol-Myers Squibb Company (NYSE:BMY) from January 27, 2015 through October 9,...

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Bristol-Myers Squibb Company (BMY)

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Bristol-Myers Squibb Company (BMY)

The Klein Law Firm announces the commencement of an investigation of Bristol-Myers Squibb Company (NYSE: BMY) concerning possible violations of federal securities laws.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Bristol-Myers Squibb Company To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Bristol-Myers Squibb Company To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Bristol-Myers Squibb Company

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Bristol-Myers Squibb Company

The Klein Law Firm announces the commencement of an investigation of Bristol-Myers Squibb Company (NYSE: BMY) concerning possible violations of federal securities laws.

BMY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Bristol-Myers Squibb Company

BMY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Bristol-Myers Squibb Company

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Bristol-Myers Squibb Company ("Bristol-Myers" or the "Company") (NYSE: BMY) violated federal securities laws.

3 Reasons Pfizer May Want to Buy Bristol-Myers Squibb

3 Reasons Pfizer May Want to Buy Bristol-Myers Squibb

Could Pfizer really buy Bristol-Myers Squibb? Despite the latter's $112 billion market cap, Citi analyst Andrew Baum lays out the case for why it makes sense.

Bristol-Myers 'Is Back' and Could Soar Another 14%

Bristol-Myers 'Is Back' and Could Soar Another 14%

Could Bristol-Myers Squibb stock really jump another 14% after rallying 12% so far in 2018? According to Morgan Stanley, the answer is 'yes.'

A Rally With Weak Breadth

The rebound continues but with weaker breadth than you might expect.

These Were the 3 Hottest Stories on Wall Street Thursday

These Were the 3 Hottest Stories on Wall Street Thursday

All three major indices gained more than 1% Thursday.

Jim's Daily Rundown

Jim discusses his Real Money article from this morning, Waste Management's earnings, and more!

TheStreet Quant Rating: C (Hold)